Amanta Healthcare IPO lists at 7% premium on stock market debut
AI-Generated Summary
Amanta Healthcare, a pharmaceutical company, made a strong debut on the stock market, listing at a premium of over 7% on both the NSE and BSE. The IPO, which aimed to raise Rs 126 crore, saw overwhelming investor interest with a total subscription of 82.61 times. This successful listing resulted in profits for investors and was in line with pre-debut expectations, reflecting confidence in the company's fundamentals.
In a nutshell
This successful IPO debut for a pharmaceutical company underscores strong investor confidence in the healthcare sector, particularly for firms with specialized product offerings. The significant oversubscription and premium listing indicate a healthy market appetite for well-regarded companies in this domain.
Source: India Today
